Ulrich Gerigk

Medicine · Health Sciences

10h-index1.2kcitations32works0.02yr avg
OpenAlex↗Google Scholar↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Lung Cancer Treatments and Mutations(24), Cancer Genomics and Diagnostics(8), RNA modifications and cancer(5), Lung Cancer Research Studies(5), Fibroblast Growth Factor Research(4)

Publications32 total

Data from Clinical and Pathological Characteristics of <i>KEAP1</i>- and <i>NFE2L2</i>-Mutated Non–Small Cell Lung Carcinoma (NSCLC)
2023Open Access
Supplemental Table 8 from Clinical and Pathological Characteristics of <i>KEAP1</i>- and <i>NFE2L2</i>-Mutated Non–Small Cell Lung Carcinoma (NSCLC)
2023Open Access
Supplement from Clinical and Pathological Characteristics of <i>KEAP1</i>- and <i>NFE2L2</i>-Mutated Non–Small Cell Lung Carcinoma (NSCLC)
2023Open Access
Supplement from Clinical and Pathological Characteristics of <i>KEAP1</i>- and <i>NFE2L2</i>-Mutated Non–Small Cell Lung Carcinoma (NSCLC)
2023Open Access
Data from Clinical and Pathological Characteristics of <i>KEAP1</i>- and <i>NFE2L2</i>-Mutated Non–Small Cell Lung Carcinoma (NSCLC)
2023Open Access
Supplemental Table 8 from Clinical and Pathological Characteristics of <i>KEAP1</i>- and <i>NFE2L2</i>-Mutated Non–Small Cell Lung Carcinoma (NSCLC)
2023Open Access
Co-occurrence of targetable mutations in Non-small cell lung cancer (NSCLC) patients harboring MAP2K1 mutations
Lung Cancer·2020· 23 cited
K-ras Mutation Subtypes in NSCLC and Associated Co-occuring Mutations in Other Oncogenic Pathways
Journal of Thoracic Oncology·2018· 247 citedOpen Access
Clinical and Pathological Characteristics of <i>KEAP1</i> - and <i>NFE2L2</i> -Mutated Non–Small Cell Lung Carcinoma (NSCLC)
Clinical Cancer Research·2018· 161 cited
Co-occurrence of targetable aberrations in non-small cell lung cancer patients harboring <i>MAP2K1</i> mutations.
Journal of Clinical Oncology·2017
P2.03b-036 Analysis of Potentially Targetable Mutations in 821 Patients with Squamous cell Lung Cancer Undergoing Routine NGS-Based Molecular Diagnostics
Journal of Thoracic Oncology·2017Open Access
Clinicopathological Characteristics of RET Rearranged Lung Cancer in European Patients
Journal of Thoracic Oncology·2016· 95 citedOpen Access
3131 Clinical and molecular characteristics of non-small cell lung cancer in patients harboring CTNNB1 mutations
European Journal of Cancer·2015
3125 KEAP1-mutations and NFE2L2-mutations in patients with non-small cell lung cancer (NSCLC)
European Journal of Cancer·2015
Implementation of Amplicon Parallel Sequencing Leads to Improvement of Diagnosis and Therapy of Lung Cancer Patients
Journal of Thoracic Oncology·2015· 94 citedOpen Access
Genetic variability and clinical presentation of patients with non-small cell lung cancer (NSCLC) harboring <i>MET</i>-amplifications.
Journal of Clinical Oncology·2015
<i>KEAP1</i>-mutations in patients with non-small cell lung cancer (NSCLC).
Journal of Clinical Oncology·2015· 1 cited
<i>ROS1</i> rearrangement in non-small cell lung cancer (NSCLC): Prognostic and predicitve impact and genetic variability.
Journal of Clinical Oncology·2015
Clinical and molecular characteristics of non-small cell lung cancer in patients harboring <i>CTNNB1</i> mutations.
Journal of Clinical Oncology·2015· 1 cited
<i>ROS1</i> rearrangements in lung adenocarcinoma: prognostic impact, therapeutic options and genetic variability
Oncotarget·2015· 93 citedOpen Access
page 1 of 2Next →

Frequent Co-authors

Sabine Merkelbach‐Bruse(28), Monika Serke(27), Matthias Scheffler(25), Reinhard Büttner(23), Sebastian Michels(22), Lukas C. Heukamp(22), Yon‐Dschun Ko(20), Jana Fassunke(17), Rieke Fischer(16), Jürgen Wolf(16), Michaela A. Ihle(15), Britta Kaminsky(15), Rebecca Roth(12), Anna Eisert(12), Rieke Frank(12), Carina Heydt(11), Anna Kron(10), Lucia Nogová(8), Marc Bos(8), Walburga Engel-Riedel(8)